(NASDAQ:RVMD), REDWOOD CITY, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company's chief executive officer and chairman, will deliver a corporate presentation as part of the 44th Annual J.P. […]
(NYSE:PNNT), MIAMI, Jan. 05, 2026 (GLOBE NEWSWIRE) — PennantPark Investment Corporation (the “Company”) (NYSE: PNNT) declares its monthly distribution for January 2026 of $0.08 per share, payable on February 2, 2026 to stockholders of record as of January 16, 2026. The distribution is expected to be paid from taxable net investment income. The final specific
(NASDAQ:BELFA),(NASDAQ:BELFB), WEST ORANGE, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) — Bel Fuse Inc. (Nasdaq: BELFA and BELFB), a leading global manufacturer of products that power, protect and connect electronic circuits, today announced its participation in the 28th Annual Needham Growth Conference. 28th Annual Needham Growth ConferenceFarouq Tuweiq, CEOLynn Hutkin, CFOTuesday, January 13, 2026Lotte NY Palace
(NASDAQ:SVCO), SANTA CLARA, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) — Silvaco Group, Inc. (Nasdaq: SVCO) (“Company”, “Silvaco”), a provider of TCAD, EDA software, and SIP solutions that enable innovative semiconductor design and digital twin modeling through AI software and innovation, will participate in a fireside chat, with Chief Executive Officer Walden Rhines as the speaker
(NASDAQ:OM), SAN JOSE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) — Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that Chair & CEO Leslie Trigg will present at the 44th annual J.P. Morgan Healthcare conference on Wednesday, January 14, 2026,
(NYSE:PFLT),(TASE:PFLT.TA), MIAMI, Jan. 05, 2026 (GLOBE NEWSWIRE) — PennantPark Floating Rate Capital Ltd. (the “Company”) (NYSE: PFLT) declares its monthly distribution for January 2026 of $0.1025 per share, payable on February 2, 2026 to stockholders of record as of January 16, 2026. The distribution is expected to be paid from taxable net investment income. The
The Lovesac Company Announces Participation in the 2026 ICR Conference GlobeNewswire January 05, 2026 STAMFORD, Conn., Jan. 05, 2026 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, announced today that the Company is
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire January 05, 2026 SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today
Covenant Logistics Group, Inc. Announces Timing of Fourth Quarter Earnings Release and Conference Call GlobeNewswire January 05, 2026 CHATTANOOGA, Tenn., Jan. 05, 2026 (GLOBE NEWSWIRE) — Covenant Logistics Group, Inc. (NYSE: CVLG) announced its plans to release its fourth quarter earnings after 4:00 p.m. Eastern time on Thursday, January 29, 2026. Covenant Logistics Group, Inc.
AVITA Medical Announces Changes to its Board of Directors GlobeNewswire January 05, 2026 Veteran healthcare executive Joe Woody joins the Board Lou Panaccio retires after over a decade of service VALENCIA, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) — AVITA Medical(R), Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions,